Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1998-11-25
2000-06-20
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514671, A01N 3302
Patent
active
060778725
ABSTRACT:
The present invention relates to the use of calcium L-threonate, namely, to a method for preventing, inhibiting and curing osteoporosis and rickets using calcium L-threonate.
REFERENCES:
patent: 5070085 (1991-12-01), Markham
Boutsen et al., "Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intermittent Intravenous Pamidronate: A Randomized Trial", Caleif Tissue Int 61:266-271, 1997.
Luengo et al., "Prevention of Further Bone Mass Loss by Nasal Calcitonin in Patients on Long Term Glucocorticoid Therapy for Asthma: A Two Year Follow-Up Study", Thorax 49:1099-1102, 1994.
Okonofua et al., "Rickets in Nigerian Children: A Consequence of Calcium Malnutrition", Metabolism 40:209-213, 1991.
Recker et al., "Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women", Annals of Internal Medicine 87:649-655, 1977.
Kou Fuping
Wang Zhiwen
Yu Kai
Beijing Jueng Asia Pacific Life Scientific Research Center
Criares Theodore J.
LandOfFree
Use of calcium L-threonate in preventing, inhibiting and curing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of calcium L-threonate in preventing, inhibiting and curing , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of calcium L-threonate in preventing, inhibiting and curing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1854013